anti human complement factor b af2739 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
90
Structured Review
R&D Systems
anti human complement factor b af2739
Anti Human Complement Factor B Af2739, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+factor+b/Human+Complement+Factor+B+Antibody/pm38683124-76-7-12
Average 90 stars, based on 6 article reviews
Anti Human Complement Factor B Af2739, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+factor+b/Human+Complement+Factor+B+Antibody/pm38683124-76-7-12
Average 90 stars, based on 6 article reviews
anti human complement factor b af2739 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Incubation:Article Title: A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera. Article Snippet: RESEARCH ARTICLE | APRIL 29 2024 A Signi cant Contribution of the Classical Pathway of Complement in SARS- CoV-2 Neutralization of Convalescent and Vaccinee Sera Patrick Budylowski; ... et. al J Immunol ji2300320. https://doi.org/10.4049/jimmunol.2300320 Related Content Characterization of CD8 +T cells recognizing a dominant epitope of SARS-CoV-2 spike protein in COVID-19 convalescent, vaccinated, and unexposed individuals J Immunol (May,2023) Variability in Severe Acute Respiratory Syndrome Coronavirus 2 IgG Antibody A nity to Omicron and Delta Variants in Convalescent and Community mRNA-Vaccinated Individuals Immunohorizons (May,2022) Characterization of SARS-CoV-2-speci c CD8+ T cells in COVID-19 convalescent, vaccinated, and individuals with respect to age J Immunol (May,2022) D ow nloaded from http://journals.aai.org/jim m unol/article-pdf/doi/10.4049/jim m unol.2300320/1656538/ji2300320.pdf by guest on 04 M ay 2024 A Significant Contribution of the Classical Pathway of other:Article Title: Complement factor B analogs and their uses Article Snippet: The assay was a sandwich immunoassay based on BioVeris's ECL Technology. Article Title: Complement factor B analogs and their uses Article Snippet: The assay was a sandwich immunoassay based on BioVeris's ECL Technology. |